QMS Medical Allied Services LimitedQMSMEDICorporate

Medical Equipment & Supplies Latest results: Jun 2026 14 quarters of data

₹171.06

MCap ₹331 Cr · P/E 49.6

QMS Medical Allied Services Limited — Stock analysis & AI research QMS Medical Allied Services Limited — Seasonality — best & worst months QMS Medical Allied Services Limited — Technical setup — score, trend, support & resistance QMS Medical Allied Services Limited — Live exchange announcements

📈 SuperTrend Bearish Signal 📈 Relative Strength Leaders 📈 Volume Dry-Up Stocks 📈 Multi-Timeframe Bullish Stocks 📈 Accumulation (OBV Rising) 🏭 Healthcare sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹52 Cr

Sales · Jun 2026

+23.7% YoY

₹7 Cr

Operating Profit · Jun 2026

+11.8% YoY

13.4%

OPM % · Jun 2026

-9.5% YoY

₹3 Cr

Net Profit · Jun 2026

-0.8% YoY

₹1.38

EPS · Jun 2026

-8.6% YoY

📝 QMS Medical Allied Services Limited — results explained

Quarter ended June 2026 (Q1 FY27)

QMS Medical Allied Services Limited reported revenue of ₹52 crore for the quarter ended June 2026 (Q1 FY27), up 23.7% from ₹42 crore in the same quarter last year, and up 33.6% sequentially over the March 2026 quarter.

Net profit fell 0.8% year-on-year to ₹3 crore, from ₹3 crore. Earnings per share (EPS) came in at ₹1.38.

Operating profit stood at ₹7 crore — an operating margin (OPM) of 13.4%, compared with 14.8% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, QMS Medical Allied Services Limited posted revenue of ₹152 crore, a growth of 5.1% over FY25, with a net profit of ₹7 crore (down 47.9% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹162 crore with a net profit of ₹7 crore.

Valuation snapshot

At the current price of ₹171.06, QMSMEDI has a market capitalisation of ₹331 crore and a trailing P/E of about 49.6.

Within the Medical Equipment & Supplies industry, it is the 6th-largest of the 13 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 68.11%, foreign institutional investors (FIIs) 0.00%, domestic institutional investors (DIIs) 1.59%, public shareholders 30.30% of QMS Medical Allied Services Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹331 Cr

Current Price ?

₹171.1

P/E ?

49.63above ind

Industry P/E ?

26.90

P/B ?

3.18

P/S ?

2.04

P/FCF ?

17.41

Enterprise Value ?

₹422 Cr

EV/EBITDA ?

19.85

PEG ?

24.81

Earnings Yield ?

4.1%

Dividend Yield ?

0.29%

Profitability & Returns

Sales (TTM) ?

₹162 Cr

OPM ?

13.1%

Profit after tax (TTM) ?

₹7 Cr

EPS (TTM) ?

₹3.45

ROCE ?

11.0%

ROE ?

6.4%

ROA ?

3.0%

Growth

Sales — latest qtr ?

₹52 Cr

PAT — latest qtr ?

₹3 Cr

YoY qtr sales growth ?

23.7%

YoY qtr profit growth ?

-0.8%

Sales growth (3y) ?

14%

Sales growth (5y) ?

Profit growth (3y) ?

Profit growth (5y) ?

-9%

Financial Health

Debt ?

₹91 Cr

Debt to Equity ?

0.88

Interest Coverage ?

2.2

Current Ratio ?

N/A

Ownership

Promoter holding ?

68.11%

Change in promoter holding ?

-5.56%

Pledged percentage ?

N/A

Market

Return 3 months ?

55.8%

Return 6 months ?

116.5%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	52	26	29	35	32	30	33	39	42	42	41	30	39	52	+23.7%	+33.6%
Operating Profit	7	5	5	5	4	5	5	5	8	6	6	4	4	7	+11.8%	+61.4%
Other Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	+62.1%	+252.0%
Interest	1	1	1	1	1	1	0	1	3	2	2	2	2	2	+16.3%	-12.5%
Depreciation	1	1	1	1	1	1	2	1	1	1	1	1	1	1	+72.2%	+29.2%
Profit Before Tax	6	3	3	3	2	3	7	3	4	4	4	1	1	4	-0.0%	+267.7%
Net Profit	4	2	3	2	2	2	5	2	3	3	3	1	1	3	-0.8%	+247.2%
EPS	2.30	1.38	1.33	1.37	0.86	1.34	1.35	1.31	1.59	1.51	1.45	0.30	0.40	1.38	-8.6%	+245.0%
OPM %	13.0%	17.9%	17.1%	13.7%	12.2%	15.9%	16.3%	13.6%	18.5%	14.8%	14.9%	12.8%	11.1%	13.4%	-9.5%	+20.7%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	FY25	FY26	TTM	YoY %
Sales	₹145 Cr	₹152 Cr	₹162 Cr	+5.1%
Operating Profit	₹23 Cr	₹21 Cr	₹21 Cr	-12.1%
OPM %	16.11%	13.46%	13.09%	-16.4%
NPM %	8.85%	4.39%	4.11%	-50.4%
Other Income	₹1 Cr	₹0 Cr	₹0 Cr	-33.0%
Depreciation	₹4 Cr	₹4 Cr	₹4 Cr	-15.8%
Interest	₹5 Cr	₹8 Cr	₹8 Cr	+51.4%
EBIT	₹19 Cr	₹17 Cr	₹17 Cr	-11.3%
PBT	₹18 Cr	₹9 Cr	₹9 Cr	-46.8%
Tax	₹4 Cr	₹2 Cr	₹2 Cr	-34.9%
Net Profit	₹13 Cr	₹7 Cr	₹7 Cr	-47.9%
EPS	₹5.59	₹3.66	₹3.53	-34.5%
Material Cost	₹43 Cr	₹75 Cr	₹77 Cr	+75.5%
Employee Cost	₹4 Cr	₹8 Cr	₹16 Cr	+110.1%
Extraordinary Items	—	—	—	—

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	18	18	18	19	+5.6%
Reserves	53	61	70	85	+21.4%
Borrowings	26	2	28	91	+225.0%
Other Liabilities	22	54	73	25	-65.8%
Total Liabilities	118	135	189	220	+16.4%
Fixed Assets	25	24	22	27	+22.7%
CWIP	1	2	3	0	-100.0%
Investments	0	2	48	63	+31.2%
Other Assets	91	108	115	130	+13.0%
Total Assets	118	135	189	220	+16.4%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	-8	1	18	19	+5.6%
Cash from Investing Activity	-25	-2	-48	-18	+62.5%
Cash from Financing Activity	32	-1	-2	-1	+50.0%
Net Cash Flow	-1	-1	-32	-0	+100.0%
Free Cash Flow	-9	1	18	19	+5.6%
CFO/OP	-47%	26%	98%	105%	+7.1%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	137	124	104	142	+36.5%
Inventory Days	140	172	176	191	+8.5%
Days Payable	91	90	74	75	+1.4%
Cash Conversion Cycle	187	205	206	258	+25.2%
Working Capital Days	138	244	224	93	-58.5%
ROCE %	14%	17%	21%	11%	-47.6%

👥 Shareholding (latest 4 periods)

Metric	Mar 2025	Jun 2025	Sep 2025	Mar 2026	% Chg
Promoters	73.67%	73.67%	68.11%	68.11%	+0.0%
FIIs	0.01%	0.01%	0.01%	0.00%	-100.0%
DIIs	0.00%	0.00%	1.60%	1.59%	-0.6%
Public	26.33%	26.33%	30.28%	30.30%	+0.1%
No. of Shareholders	1,519	1,489	1,564	1,499	-4.2%

⚖️ Peer comparison

Industry: Medical Equipment & Supplies · 13 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	FISCHER Fischer Medical	₹33.50	2,293	85.2	367	24	12.3%	6.7%	178.6%	2051.4%	249.4%	-24.3%
2	TARSONS Tarsons Products	₹330.00	1,756	157.9	441	11	27.0%	2.5%	-66.3%	-81.4%	20.7%	-181.0%
3	DENTALKART Vasa Denticity	₹563.10	977	80.0	299	12	4.4%	4.0%	16.7%	-28.5%	12.9%	-2.9%
4	543916 Hemant Surgical	₹193.85	544	13.9	231	18	10.4%	7.8%	—	—	187.9%	160.0%
5	543363 Prevest Denpro	₹616.50	456	32.8	75	23	35.7%	29.9%	13.6%	17.6%	23.7%	24.8%
6	QMSMEDI QMS Medical	₹185.89	359	52.7	162	7	13.1%	4.1%	5.1%	-47.9%	23.7%	-0.8%
7	NURECA Nureca	₹331.55	331	75.9	153	4	2.7%	2.8%	34.0%	146.7%	18.0%	277.2%
8	530427 Choksi Asia	₹65.64	122	7.2	47	5	14.5%	11.1%	61.1%	173.2%	-22.5%	-10.1%
9	527005 Shree Pacetronix	₹168.25	55	19.2	21	3	24.8%	15.3%	28.7%	324.3%	-8.3%	14.5%
10	544143 Royal Sense	₹139.00	47	24.7	38	3	12.8%	8.0%	—	—	2.5%	-5.4%
11	533212 GKB Ophthalmics	₹104.90	32	17.6	150	6	7.0%	3.7%	36.8%	142.7%	2.3%	388.5%
12	531380 Centenial Surgical	₹110.90	27	—	56	-1	10.7%	-2.6%	0.6%	-38.1%	18.6%	1937.8%
13	542765 Transpact Enterprises	₹325.00	4	140.1	0	0	63.2%	47.4%	—	—	12.5%	-20.0%

❓ Frequently asked questions

What was QMS Medical Allied Services Limited's revenue in Q1 FY27?

What was QMS Medical Allied Services Limited's net profit in Q1 FY27?